Taisuke Nomoto

Antitumor effects of butyrolactone I, a selective cdc2 kinase inhibitor, on human lung cancer cell lines.

Kohei Nishio, Tomohisa Ishida, Hitoshi Arioka et al. · PubMed · 1997 · 57 citations

Medicine, Oncology, Pharmacology +15

Clinicopathological significance of aberrant methylation of RARβ2 at 3p24, RASSF1A at 3p21.3, and FHIT at 3p14.2 in patients with non-small cell lung cancer

Yoshio Tomizawa, Hironobu Iijima, Taisuke Nomoto et al. · Lung Cancer · 2004 · 57 citations

Medicine, Genetics, Oncology +15

Primary Racemose Hemangioma of the Bronchial Artery.

Motoki Iwasaki, Hiroyuki Kobayashi, Taisuke Nomoto et al. · Internal Medicine · 2001 · 33 citations · Full text

Medicine, Pathology, Surgery +9

Identification ofcis-Acting DNA Elements of the Human γ-Glutamylcysteine Synthetase Heavy Subunit Gene

Akira Tomonari, Kazuto Nishio, Hirokazu Kurokawa et al. · Biochemical and Biophysical Research Communications · 1997 · 31 citations

Life Sciences, Genetics, Molecular Biology +6

Enhancement of Cisplatin Sensitivity in High Mobility Group 2 cDNA‐transfected Human Lung Cancer Cells

Hitoshi Arioka, Kazuto Nishio, Tomoyuki Ishida et al. · Japanese Journal of Cancer Research · 1999 · 30 citations · Full text

Life Sciences, Genetics, Oncology +8